Compression textiles as adjuvant physical interventions are increasingly applied for prophylaxis and treatment of chronic venous insufficiency (CVI), providing benefits of calibrated compression and controlled stretch. Pressure dosage delivered and mechanical properties (stiffness, elasticity and hysteresis) are determined by material nature, stitches structures, fabrication technology and delivery modes. Laplace’s Law and Pascal’s Law contribute to elaborate the static and dynamic working mechanisms behind the interaction between compression interventions and a biological body. However, there is still a lack of sufficient awareness on compression materials, and there is controversy regarding the best solution for clinical application of compression. This study integrates the views from physiology, pathophysiology, biomechanics, material science and textile engineering, to review and clarify physical–mechanical characteristics of compression materials, working mechanisms of textile-based compression interventions and their medical benefits in chronic venous insufficiency treatment. The aim is to enhance understanding of compression textiles applied in compression therapy, and to facilitate cooperation among multiple parties working in related supply chains, thus promoting textile-based compression interventions in chronic venous insufficiency treatment and growth of technical textiles applied in healthcare, medical and rehabilitation fields.

No abstract

Abnormal metabolism and uncontrolled angiogenesis are two important characteristics of malignant tumors. The occurrence of both events involves many key molecular changes including miRNA. However, EBV encoded miRNAs are rarely mentioned as capable of regulating tumor metabolism and tumor angiogenesis. Here, we reported that one of the key miRNAs encoded by EBV, EBV-miR-Bart1-5P, can significantly promote nasopharyngeal carcinoma (NPC) cell glycolysis and induces angiogenesis in vitro and in vivo. Mechanistically, EBV-miR-Bart1-5P directly targets the α1 catalytic subunit of AMP-activated protein kinase (AMPKα1) and consequently regulates the AMPK/mTOR/HIF1 pathway which impelled NPC cell anomalous aerobic glycolysis and angiogenesis, ultimately leads to uncontrolled growth of NPC. Our findings provide new insights into metabolism and angiogenesis of NPC and new opportunities for the development of targeted NPC therapy in the future.

No abstract

Objective To identify patient-care practices related to an increased prevalence of hepatitis C virus (HCV) infection among chronic hemodialysis patients. Design Survey Setting Chronic hemodialysis facilities in the United States Participants An equal probability two-stage cluster sampling was used to select 87 facilities from all Medicare-approved providers treating 30–150 patients; 53 facilities and 2933/3680 eligible patients agreed to participate. Methods Patients were tested for HCV antibody and HCV RNA. Data on patient-care practices were collected using direct observation. Results Overall prevalence of HCV infection was 9.9% (95% confidence interval [CI], 8.2–11.6); only 2/294 HCV-positive patients were detected solely by HCV RNA. After adjusting for non-dialysis-related HCV risk factors, patient-care practices independently associated with higher prevalence of HCV infection included reusing priming receptacles without disinfection (odds ratio [OR] 2.3; 95% CI, 1.4–3.9), handling blood specimens adjacent to medications and clean supplies (OR 2.2; 95% CI, 1.3–3.6), and using mobile carts to deliver injectable medications (OR 1.7; 95% CI, 1.0–2.8). Independently-related facility covariates were ≥10% patient HCV prevalence (OR 3.0; 95% CI, 1.8–5.2), patient-to-staff ratio ≥7-to-1 (OR 2.4; 95% CI, 1.4–4.1), and treatment duration ≥2 years (OR 2.4; 95% CI, 1.3–4.4). Conclusions This study provides the first epidemiologic evidence of associations between specific patient-care practices and higher HCV infection prevalence among hemodialysis patients. Staff should review practices to ensure that hemodialysis-specific infection control practices are being implemented, especially handling clean and contaminated items in separate areas, reusing items only if disinfected, and prohibiting mobile medication/clean supply carts within treatment areas.

No abstract

The current methods available for screening and detecting cervical squamous cell carcinoma (CSCC) have insufficient sensitivity and specificity. As a result, many patients suffered from erroneous and missed diagnosis. Because CSCC is usually asymptomatic at potentially curative stages, identification of biomarkers is an urgent need for the early detection of CSCC. Comparative proteomics based on two-dimensional differential in-gel electrophoresis (2D-DIGE) was employed to quantitatively analyze plasma proteins of healthy Uyghur women and with early stage cervical carcinoma. The 2D-DIGE image were analyzed statistically using DeCyder™ 2D software. The statistical analysis of proteomic data revealed that 43 protein spots showed significantly different expression (ratio > 1.5, P < 0.01). A further identification of these protein spots by MALDI-TOF-MS found out 16 different proteins. Bioinformatic analysis within the framework of Ingenuity Pathway Analysis (IPA(@)) showed that 10 plasma proteins as candidate biomarker were screened, mainly including lipid metabolism-related proteins (APOA4, APOA1, APOE), complement (EPPK1, CFHR1), metabolic enzymes (CP, F2, MASP2), glycoprotein (CLU), and immune function-related proteins (IGK@). Networks involved in lipid metabolism, molecular transport, and small molecule biochemistry were dysfunctional in CSCC. Acute phase response signaling and JAK/Stat signaling and IL-4 signaling, etc., were identified as the canonical pathways that are overrepresented in CSCC. Furthermore, the expression of three proteins (APOA1, APOE, CLU) were validated using ELISA in plasma of patients with different stage cervical lesion. With the combined proteomic and bioinformatic approach, this study was successful in identifying biomarker signatures for cervical cancer and might provide new insights into the mechanism of CSCC progression, potentially leading to the design of novel diagnostic and therapeutic strategies.

No abstract